Psychopharmacology

, Volume 181, Issue 1, pp 107–117

Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse

  • Mustafa al’Absi
  • Dorothy Hatsukami
  • Gary L. Davis
Original Investigation

Abstract

Rationale

Research has demonstrated that psychosocial stressors increase smoking and risk for smoking relapse. Alterations in biological systems involved in the stress response caused by chronic smoking may contribute to early relapse.

Objectives

We examined the extent to which pituitary–adrenocortical and cardiovascular responses to stress following the first 24 h of a quit attempt predict early relapse.

Methods

Seventy-two smokers interested in cessation attended a laboratory stress session 24 h after the beginning of their cessation attempt. Adrenocorticotropin (ACTH), plasma and salivary cortisol concentrations, systolic and diastolic blood pressure (BP), and heart rate (HR) responses to acute psychological stressors (public speaking and cognitive challenges) were used to predict relapse over a 4-week follow-up period.

Results

Those who relapsed within 4 weeks showed attenuated hormonal and cardiovascular responses to stress and exaggerated withdrawal symptoms. Cox proportional hazards survival analysis showed that attenuated ACTH, plasma cortisol, systolic and diastolic BP, positive affect, and exaggerated withdrawal symptoms and smoking urges during acute stress predicted early relapse. Stepwise model showed that ACTH, diastolic BP, and exaggerated withdrawal symptoms remain as significant predictors. When baseline smoking and psychological measures were included in the model, changes in ACTH, diastolic BP, and both factors of smoking urges remained significant predictors of relapse.

Conclusions

These results demonstrate that altered stress response predicts increased vulnerability for smoking relapse.

Keywords

Stress Smoking Relapse Adrenocorticotropic hormone Withdrawal symptoms Cortisol Cardiovascular responses 

References

  1. al’Absi M, Lovallo WR, McKey B, Pincomb G (1994) Borderline hypertensives produce exaggerated adrenocortical responses to mental stress. Psychosom Med 56:245–250PubMedGoogle Scholar
  2. al’Absi M, Bongard S, Buchanan T, Pincomb GA, Licinio J (1997) Cardiovascular and neuroendocrine adjustment to public speaking and mental arithmetic stressors. Psychophysiology 34:266–275PubMedCrossRefGoogle Scholar
  3. al’Absi M, Lovallo WR, McKey B, Sung BH, Whitsett TL, Wilson MF (1998) Hypothalamic–pituitary–adrenocortical responses to psychological stress and caffeine in men at high and low risk for hypertension. Psychosom Med 60:521–527PubMedGoogle Scholar
  4. al’Absi M, Amunrud T, Wittmers LE (2002) Psychophysiological effects of abstinence and behavioral challenges in habitual smokers. Pharmacol Biochem Behav 72:707–716CrossRefPubMedGoogle Scholar
  5. al’Absi M, Wittmers LE, Erickson J, Hatsukami DK, Crouse B (2003) Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers. Pharmacol Biochem Behav 74:401–410CrossRefPubMedGoogle Scholar
  6. al’Absi M, Hatsukami D, Davis GL, Wittmers LE (2004) Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend 73:267–278CrossRefPubMedGoogle Scholar
  7. Brown RA, Lejuez CW, Kahler CW, Strong DR (2002) Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol 111:180–185CrossRefPubMedGoogle Scholar
  8. Burgess ES, Brown RA, Kahler CW, Niaura R, Abrams DB, Goldstein MG, Miller IW (2002) Patterns of change in depressive symptoms during smoking cessation: who’s at risk for relapse? J Consult Clin Psychol 70:356–361CrossRefPubMedGoogle Scholar
  9. Cacioppo JT (1994) Social neuroscience: autonomic, neuroendocrine, and immune response to stress. Psychophysiology 31:113–128PubMedCrossRefGoogle Scholar
  10. Carey MP, Kalra DL, Carey KB, Halperin S, Richards CS (1993) Stress and unaided smoking cessation: a prospective investigation. J Consult Clin Psychol 61:831–838CrossRefPubMedGoogle Scholar
  11. Christensen N (1994) Effect of psychosocial stress and age on plasma norepinephrine levels: a review. Psychosom Med 56:77–83PubMedGoogle Scholar
  12. Cohen S, Lichtenstein E (1990) Perceived stress, quitting smoking, and smoking relapse. Health Psychol 9:466–478CrossRefPubMedGoogle Scholar
  13. Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–396PubMedCrossRefGoogle Scholar
  14. Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3:7–16CrossRefPubMedGoogle Scholar
  15. Curvall M, Elwin CE, Kazemi-Vala E, Warholm C, Enzell CR (1990) The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol 38:281–287CrossRefPubMedGoogle Scholar
  16. Dallman M (1993) Stress update: adaptation of the hypothalamic–pituitary–adrenal axis to chronic stress. Trends Endocrinol Metab 4:62–69CrossRefPubMedGoogle Scholar
  17. Deroche V, Marinelli M, Le Moal M, Piazza P (1997) Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous self-administration and reinstatement depend on Glucocortoid levels. J Pharmacol Exp Ther 281:1401–1407PubMedGoogle Scholar
  18. Dressendorfer RA, Kirschbaum C, Rohde W, Stahl F, Strasburger CJ (1992) Synthesis of a cortisol–biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 43:683–692CrossRefPubMedGoogle Scholar
  19. Emmons KM, Weidner G, Lorraine C (1989) Smoking cessation and cardiovascular reactivity to stress. J Behav Med 12:587–598CrossRefPubMedGoogle Scholar
  20. Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB, Covey LS (1988) Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 259:2863–2866CrossRefPubMedGoogle Scholar
  21. Gronwall D (1977) Paced auditory serial addition task: a measure of recovery from concussion. Percept Mot Skills 44:373Google Scholar
  22. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict 86:1119–1127PubMedCrossRefGoogle Scholar
  23. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294PubMedGoogle Scholar
  24. Hughes J, Hatsukami DK (1998) Errors in using tobacco withdrawal scale. Tob Control 7:92–93PubMedCrossRefGoogle Scholar
  25. Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB (2002) Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol 70:216–227CrossRefPubMedGoogle Scholar
  26. Kirschbaum C, Wust S, Strasburger CJ (1992) Normal cigarette smoking increases free cortisol in habitual smokers. Life Sci 50:435–442CrossRefPubMedGoogle Scholar
  27. Koob GF, Heinrichs SC (1999) A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848:141–152CrossRefPubMedGoogle Scholar
  28. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52–57CrossRefPubMedGoogle Scholar
  29. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, Britton KT (1993) The role of corticotropin-releasing factor in behavioral responses to stress. CIBA Found Symp 172. In: Chadwick DJ, Marsh S, Ackrill K (eds) Corticotropin-releasing factor. Wiley, Chichester, pp 277–295CrossRefGoogle Scholar
  30. Kosten TA, Ambrosio E (2002) HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 27:35–69CrossRefPubMedGoogle Scholar
  31. Majewska MD (2002) HPA axis and stimulant dependence: an enigmatic relationship. Psychoneuroendocrinology 27:5–12CrossRefPubMedGoogle Scholar
  32. Makino S, Gold PW, Schulkin J (1994a) Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640:105–112CrossRefPubMedGoogle Scholar
  33. Makino S, Gold PW, Schulkin J (1994b) Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 657:141–149CrossRefPubMedGoogle Scholar
  34. McEwen BS, Sapolsky RM (1995) Stress and cognitive function. Curr Opin Neurobiol 5:205–216CrossRefPubMedGoogle Scholar
  35. McEwen BS, Stellar E (1993) Stress and the individual: mechanisms leading to disease. Arch Intern Med 153:2093–2101CrossRefPubMedGoogle Scholar
  36. McNair DM, Lorr M, Droppleman LF (1992) POMS Manual—Profile of Mood Questionnaire. San Diego, EditsGoogle Scholar
  37. Mills PJ, Dimsdale JE (1992) Sympathetic nervous system responses to psychosocial stressors. In: Turner JR (ed) Individual differences in cardiovascular responses to stress. Plenum Press, New York, pp 33–50Google Scholar
  38. Parrott A (1999) Does cigarette smoking cause stress? Am Psychol 54:817–820CrossRefPubMedGoogle Scholar
  39. Pavcovich LA, Valentino RJ (1997) Regulation of a putative neurotransmitter effect of corticotropin-releasing factor: effects of adrenalectomy. J Neurosci 17:401–408PubMedGoogle Scholar
  40. Perkins K, Epstein L, Grobe J, Fonte C (1994) Tobacco abstinence, smoking cues, and the reinforcing value of smoking. Pharmacol Biochem Behav 47:107–112CrossRefPubMedGoogle Scholar
  41. Petrusz P, Merchenthaler I (1992) The corticotropin-releasing factor system. In: Nemeroff CB (ed) Neuroencocrinology. CRC Press, Boca RatonGoogle Scholar
  42. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB (2003) Smoking withdrawal dynamics. II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol 112:14–27CrossRefPubMedGoogle Scholar
  43. Piazza PV, Le Moal ML (1996) Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359–378CrossRefPubMedGoogle Scholar
  44. Piazza PV, Le Moal M (1997) Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Rev 25:359–372CrossRefPubMedGoogle Scholar
  45. Piazza PV, Le Moal M (1998) The role of stress in drug self-administration. Trends Pharmacol Sci 19:67–74CrossRefPubMedGoogle Scholar
  46. Pomerleau OF, Fertig JB, Seyler LE, Jaffe J (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81:61–67CrossRefPubMedGoogle Scholar
  47. Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRefGoogle Scholar
  48. Robledo P, Koob GF (1993) Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav Brain Res 55:159–166CrossRefPubMedGoogle Scholar
  49. Sherman E, Strauss E, Spellacy F (1997) Validity of the Paced Auditory Serial Addition Test (PASAT) in adults referred for neuropsychological assessment after head injury. Clin Neuropsychol 11:34–45CrossRefGoogle Scholar
  50. Shiffman S, Hickcox M, Paty JA, Gnys M, Kassel JD, Richards TJ (1996) Progression from a smoking lapse to relapse: prediction from abstinence violation effects, nicotine dependence, and lapse characteristics. J Consult Clin Psychol 64:993–1002CrossRefPubMedGoogle Scholar
  51. Spielberger CD, Gorsuch R, Lushene R (1983) State–trait anxiety manual. Consulting Psychological Press, Palo Alto, CAGoogle Scholar
  52. Swan GE, Ward MM, Jack LM, Javitz HS (1993) Cardiovascular reactivity as a predictor of relapse in male and female smokers. Health Psychol 12:451–458CrossRefPubMedGoogle Scholar
  53. Swan GE, Ward MM, Jack LM (1996) Abstinence effects as predictors of 28-day relapse in smokers. Addict Behav 21:481–490CrossRefPubMedGoogle Scholar
  54. Tiffany ST, Drobes DJ (1991) The development and initial validation of a questionnaire on smoking urges. Br J Addict 86:1467–1476PubMedCrossRefGoogle Scholar
  55. Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L (1971) Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocr 33:14–21PubMedCrossRefGoogle Scholar
  56. West R (1994) Beneficial effects of nicotine: reprise. Addiction 89:144–146CrossRefGoogle Scholar
  57. Wilkins JN, Carlson HE, Van Vunakis H, Hill MA, Gritz E, Jarvik ME (1982) Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology 78:305–308PubMedCrossRefGoogle Scholar
  58. Wills TA, Sandy JM, Yaeger AM (2002) Stress and smoking in adolescence: a test of directional hypotheses. Health Psychol 21:122–130CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Mustafa al’Absi
    • 1
    • 2
    • 3
  • Dorothy Hatsukami
    • 4
  • Gary L. Davis
    • 1
  1. 1.Department of Behavioral SciencesUniversity of Minnesota Medical SchoolDuluthUSA
  2. 2.Department of Family MedicineUniversity of Minnesota Medical SchoolDuluthUSA
  3. 3.Department of Physiology and PharmacologyUniversity of Minnesota Medical SchoolDuluthUSA
  4. 4.Department of PsychiatryUniversity of MinnesotaMinneapolisUSA

Personalised recommendations